KYIV. UkraineGate . 2 . October .2022 | World News .
Moderna has refused to give China the underlying intellectual property underlying the development of its COVID-19 vaccine, leading to the failure of negotiations to sell it there. This is reported by the Financial Times .
Details
A Cambridge-based pharmaceutical company has rejected China’s request to provide a prescription for its mRNA vaccine due to commercial and safety concerns, the newspaper reported, citing people who participated in negotiations that took place between 2020 and 2021, adding that the vaccine manufacturer is still “keen” to sell the product to China.
The company “abandoned” its previous attempts to enter the Chinese market due to China’s demand to transfer the technology as a precondition for sale in the country, the report said.
China has not approved any foreign vaccine against COVID-19 and relies on several vaccines developed in the country.
In September, Moderna’s chief medical officer Paul Burton said the company was committed to working with China to supply its mRNA-based COVID-19 vaccines to the country.
Recall
Unlike China, U.S. health officials on Wednesday approved updated Covid-19 vaccines from Moderna and Pfizer-BioNTech, which specifically target the latest strains of the Omicron variant to launch a new booster vaccination campaign.
Source: Ukrgate
